ArticleFrontiers in pharmacology2025

Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer.

Zicheng Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.